Session Details
[BO]Oral Presentation Award Session
Fri. Oct 11, 2024 11:05 AM - 11:55 AM JST
Fri. Oct 11, 2024 2:05 AM - 2:55 AM UTC
Fri. Oct 11, 2024 2:05 AM - 2:55 AM UTC
Room 1(Ballroom BC, 3F)
Chairs:Takahiro Yamada(Division of Clinical Genetics, Hokkaido University Hospital), Yoshio Makita(Department of Genetic Counseling, Asahikawa Medical University Hospital)
[BO-1]Management of patients with hematological disorders with germline predispositions in Japan
○Mizuki Watanabe1,2, Junya Kanda1, Hidenori Kawasaki3, Senji Kasahara4, Nobuhiro Kanemura5, Norihiro Hiramoto6, Kensuke Usuki7, Kazunori Imada8, Yasunori Ueda9, Kinuko Mitani10, Tosiyuki Kitano11, Yukiyoshi Moriuchi12, Uoshima Nobuhiko13, Shigeo Fuji14, Seishi Ogawa15, Akifumi Takaori1, Yasuhito Nannya16 (1.Department Hematology, Kyoto University Hospital, Kyoto, Japan, 2.Div. Stem Cell Transplantation, National Cancer Center Hospital, Tokyo, Japan, 3.Clinical Genetics Unit, Kyoto University Hospital, Kyoto, Japan, 4.Department of Hematology, Gifu Municipal Hospital, Gifu, Japan, 5.Department Hematology and Infectious Disease, Gifu University Hospital, Gifu, Japan, 6.Department Hematology, Kobe City Medical Center General Hospital, Kobe, Japan, 7.Department of Hematology, NTT Medical Center Tokyo, Tokyo, Japan, 8.Department of Hematology, Japanese Red Cross Osaka Hospital, Osaka, Japan, 9.Department of Hematology, Kurashiki Central Hospital, Kurashiki, Japan, 10.Department of Hematology and Oncology, Dokkyo Medical University, Tochigi, Japan, 11.Department of Hematology, Kitano Hospital, Osaka, Japan, 12.Department of Hematology, Sasebo City General Hospital, Sasebo, Japan, 13.Department Hematology, Japanese Red Cross Kyoto Daini Hospital, Kyoto, Japan, 14.Department of Hematology, Osaka International Cancer Institute, Osaka, Japan, 15.Department Pathology and Tumor Biology, Kyoto University, Kyoto, Japan, 16.Department Hematology/Oncology, Institute of Medical Science, The University of Tokyo, Tokyo, Japan)
[BO-2]New quantitative and qualitative analytical framework of scRNAseq data reveals the pathophysiology of SLE
○Masahiro Nakano1, Michihiro Kono1,2, Hiroaki Hatano1, Kenichiro Asahara1, Takahiro Nishino1, Haruka Takahashi1,2, Bunki Natsumoto1, Kazuyoshi Ishigaki1,2,3 (1.Laboratory for Human Immunogenetics, RIKEN Center for Integrative Medical Sciences, Kanagawa, Japan, 2.Department of Microbiology and Immunology, Keio University School of Medicine, 3.Keio University Human Biology-Microbiome-Quantum Research Center (WPI-Bio2Q))
[BO-3]Germline Findings in Whole Genome Sequencing: Contribution to Carcinogenesis?
○Eri Habano1, Norio Tanaka2, Akito Dobashi3, Keika Kaneko1, Hiromi Arakawa1, Yuko Minoura1, Asami Kuga1, Kota Ishioka1, Naomi Hayashi1, Takahiro Kogawa1, Ippei Fukada1, Seiichi Mori2, Takahashi Shunji1, Takayuki Ueno1, Arisa Ueki1 (1.The Cancer Institute Hospital, Japanese Foundation for Cancer Research, 2.The Cancer Precision Medicine Center, Japanese Foundation for Cancer Research, 3.The Cancer Institute, Japanese Foundation for Cancer Research)
[BO-4]Long-term efficacy of gene therapy for AADC deficiency and development of diagnostic system
○Marina Mizobe1, Karin Kojima1, Chika Watanabe1, Shin-ichi Muramatsu2, Hitoshi Osaka1, Takanori Yamagata1,3 (1.Department of Pediatrics, Jichi Medical University, Tochigi, Japan, 2.Division of Neurological Gene Therapy, Jichi Medical University, Tochigi, Japan, 3.Tochigi Rehabilitation Center, Tochigi, Japan)